Chester County News and Community Website
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) recently reported financial results for the second quarter ended June 30, 2021, and provided a corporate update.
Immunome Reports Second Quarter 2021 Financial Results Read More EXTON, PA — Immunome, Inc. (Nasdaq: IMNM) announced that its three-antibody cocktail (IMM-BCP-01) has demonstrated potent neutralizing activity against the SARS-CoV-2 Delta variant in pre-clinical pseudovirus testing. Furthermore, IMM-BCP-01 showed …
Immunome Antibody Cocktail (IMM-BCP-01) Neutralizes the SARS-CoV-2 Delta Variant in Pre-clinical Testing Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from …
Ocugen’s COVID-19 Vaccine Demonstrating 77.8% Protection Read More EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a biopharmaceutical company that utilizes its human memory B cell discovery engine platform to discover and develop first-in-class antibody therapeutics, announced a $4.3 …
Immunome Announces Additional $4.3 Million Award by DOD Read More